Ghrelin and the endocrine pancreas

被引:42
作者
Broglio, F
Gottero, C
Benso, A
Prodam, F
Volante, M
Destefanis, S
Gauna, C
Muccioli, G
Papotti, M
van der Lely, AJ
Ghigo, E
机构
[1] Univ Turin, Dept Internal Med, Div Endocrinol & Metab, I-10124 Turin, Italy
[2] Univ Turin, Dept Pharmacol & Forens Med, I-10124 Turin, Italy
[3] Erasmus Univ, Dept Internal Med, Div Endocrinol, NL-3000 DR Rotterdam, Netherlands
关键词
ghrelin; GH secretagogues; insulin; glucose metabolism; energy balance;
D O I
10.1385/ENDO:22:1:19
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ghrelin is a 28-amino-acid peptide predominantly produced by the stomach, while substantially lower amounts derive from other tissues including the pancreas. It is a natural ligand of the GH secretagogue (GHS) receptor (GHS-R1a) and strongly stimulates GH secretion, but acylation in serine 3 is needed for its activity. Ghrelin also possesses other endocrine and nonendocrine actions reflecting central and peripheral GHS-R distribution including the pancreas. The wide spectrum of ghrelin activities includes orexigenic effect, control of energy expenditure, and peripheral gastroenteropancreatic actions. Circulating ghrelin levels mostly reflect gastric secretion as indicated by evidence that they are reduced by 80% after gastrectomy and even after gastric by-pass surgery. Ghrelin secretion is increased in anorexia and cachexia but reduced in obesity, a notable exception being Prader-Willi syndrome. The negative association between ghrelin secretion and body weight is emphasized by evidence that weight increase and decrease reduces and augments circulating ghrelin levels in anorexia and obesity, respectively, and agrees with the clear negative association between ghrelin and insulin levels. In fact, ghrelin secretion is increased by fasting whereas it is decreased by glucose load as well as during euglycemic clamp but not after arginine or free fatty acid load in normal subjects; in physiological conditions, however, the most remarkable inhibitory input on ghrelin secretion is represented by somatostatin as well as by its natural analog cortistatin that concomitantly reduce beta-cell secretion. This evidence indicates that the endocrine pancreas plays a role in directly or indirectly modulating ghrelin secretion. As anticipated, ghrelin, in turn, is expressed within the endocrine pancreas, although it is still matter of debate if it is expressed by beta-, alpha-, or non-alpha/non-beta cells. Moreover, GHS-R1a expression in the pancreas has been demonstrated by many authors. Some impact of synthetic GHS on insulin secretion and glucose metabolism had been reported in both animal and human studies. Depending on dose and experimental conditions ghrelin has been shown able to inhibit or stimulate insulin secretion in animals. In humans, ghrelin administration is followed by transient inhibition of insulin levels that surprisingly follows persistent increase in plasma glucose levels suggesting that ghrelin would also directly or indirectly activate glycogenolisis. Current studies indicate that ghrelin also blunts the insulin response to arginine but not that to oral glucose load in humans. These acute effects of ghrelin are independent of any cholinergic mediation and are not shared by synthetic, peptidyl GHS indicating they are likely mediated by a non-GHS-R1a receptor. These acute effects of ghrelin on insulin secretion would be short-lasting, and it has to be remembered that long-term treatment with synthetic non peptidyl GHS in healthy elderly subjects was followed by insulin resistance. In all, it is already clear that ghrelin has remarkable impact in modulating insulin secretion and glucose metabolism. Insulin and ghrelin secretions seem linked by a negative functional relationship that strengthens the hypothesized role of ghrelin in participating in the management of the neuroendocrine and metabolic response to variations in energy balance.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 61 条
[1]   Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats [J].
Adeghate, E ;
Ponery, AS .
JOURNAL OF NEUROENDOCRINOLOGY, 2002, 14 (07) :555-560
[2]  
Altman Jennifer, 2002, Neuroendocrinology, V76, P131, DOI 10.1159/000064528
[3]   Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans [J].
Ariyasu, H ;
Takaya, K ;
Tagami, T ;
Ogawa, Y ;
Hosoda, K ;
Akamizu, T ;
Suda, M ;
Koh, T ;
Natsui, K ;
Toyooka, S ;
Shirakami, G ;
Usui, T ;
Shimatsu, A ;
Doi, K ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Nakao, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4753-4758
[4]   Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone [J].
Arvat, E ;
Maccario, M ;
Di Vito, L ;
Broglio, F ;
Benso, A ;
Gottero, C ;
Papotti, M ;
Muccioli, G ;
Dieguez, C ;
Casanueva, FF ;
Deghenghi, R ;
Camanni, F ;
Ghigo, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1169-1174
[5]   Ghrelin and leptin pulse discharge in fed and fasted rats [J].
Bagnasco, M ;
Kalra, PS ;
Kalra, SP .
ENDOCRINOLOGY, 2002, 143 (02) :726-729
[6]   Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood [J].
Bellone, S ;
Rapa, A ;
Vivenza, D ;
Castellino, N ;
Petri, A ;
Bellone, J ;
Me, E ;
Broglio, F ;
Prodam, F ;
Ghigo, E ;
Bona, G .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (05) :RC13-RC15
[7]   Growth hormone secretagogues and hypothalamic networks [J].
Bluet-Pajot, MT ;
Tolle, V ;
Zizzari, P ;
Robert, C ;
Hammond, C ;
Mitchell, V ;
Beauvillain, JC ;
Viollet, C ;
Epelbaum, J ;
Kordon, C .
ENDOCRINE, 2001, 14 (01) :1-8
[8]   Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans [J].
Broglio, F ;
Benso, A ;
Gottero, C ;
Prodarn, F ;
Gauna, C ;
Filtri, L ;
Arvat, E ;
van der Lely, AJ ;
Deghenghi, R ;
Ghigo, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (03) :192-196
[9]   The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects [J].
Broglio, F ;
Benso, A ;
Castiglioni, C ;
Gottero, C ;
Prodam, F ;
Destefanis, S ;
Gauna, C ;
van der Lely, AJ ;
Deghenghi, R ;
Bo, M ;
Arvat, E ;
Ghigo, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1537-1542
[10]   Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans [J].
Broglio, F ;
Gottero, C ;
Benso, A ;
Prodam, F ;
Casanueva, FF ;
Dieguez, C ;
van der Lely, AJ ;
Deghenghi, R ;
Arvat, E ;
Ghigo, E .
CLINICAL ENDOCRINOLOGY, 2003, 58 (01) :92-98